Fractyl expands ERASE Task Force to study underlying GLP-1-based pancreatic gene therapy for T2DM
Fractyl Health has expanded an academic-industry scientific partnership charged with advancing research on the role of the gut and...
Fractyl expands ERASE Task Force to study underlying GLP-1-based pancreatic gene therapy for T2DM
Carmot begins Phase 2 trial of dual GLP-1/GIP RA CT-868 for the treatment of type 1 diabetes
People with obesity burn less energy during day
Journal Watch 15/11/2023
Updates on banded procedure studies and randomised controlled trials
SELECT: Semaglutide reduces CV events in non-diabetic patients with overweight or obesity